<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03996889</url>
  </required_header>
  <id_info>
    <org_study_id>VAP-AURC</org_study_id>
    <nct_id>NCT03996889</nct_id>
  </id_info>
  <brief_title>Treatment of Popliteal Aneurysms With VIABAHN Stent Graft in Elective Surgery</brief_title>
  <acronym>VAP-AURC</acronym>
  <official_title>Treatment of Popliteal Aneurysms With VIABAHN Stent Graft in Elective Surgery: Multicenter Prospective Registry of the Research in Vascular Surgery University Association (AURC)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This multicentric, prospective study will evaluate the medium-term outcomes of patients
      implanted with GORE VIABAHN® stent grafts for popliteal artery aneurysms in scheduled
      elective surgery with the registry of the Research in Vascular Surgery University Association
      (AURC)
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 2019</start_date>
  <completion_date type="Anticipated">September 2022</completion_date>
  <primary_completion_date type="Anticipated">September 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Major limb events</measure>
    <time_frame>2 years of follow-up</time_frame>
    <description>Composite criterion associating Target Lesion Revascularization (TLR) and Rate of major amputation.
An Echo-Doppler imaging examination will be performed and the following parameters and information should be collected:
Permeability
Intra-stent restenosis
Systolic pressure index</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Popliteal Aneurysm</condition>
  <arm_group>
    <arm_group_label>Popliteal aneurysm patients with GORE VIABAHN®</arm_group_label>
    <description>The study population will include all popliteal aneurysm patients treated with GORE VIABAHN® stent graft in scheduled elective surgery, whether symptomatic or asymptomatic.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Endovascular treatment of aneurysms of the popliteal artery by GORE VIABAHN® stent in elective surgery</intervention_name>
    <description>The intervention can be performed under local anesthesia (LA), regional locus (ALR) or general anesthesia (AG) (data collected) by first approach: percutaneous or conventional.
The data collected are:
Number of GORE VIABAHN® stent used (length and diameter of each)
Embolization of collaterals and other related actions
Operative complications
Intraoperative fibrinolysis
Collar cover&gt; 2 cm
Lack of overlap in the &quot;overlap zone&quot; (nb: between 4 and 8 cm above the joint spacing)
Arteriography in profile, kink</description>
    <arm_group_label>Popliteal aneurysm patients with GORE VIABAHN®</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study population will include all popliteal aneurysm patients treated with GORE
        VIABAHN® stent graft in scheduled elective surgery, whether symptomatic or asymptomatic.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &gt; 18 years old at time of treatment

          -  symptomatic or asymptomatic popliteal artery aneurysm needing surgery

          -  scheduled elective surgery

        Exclusion Criteria:

          -  life expectancy of &lt;1 year

          -  thrombotic occlusion of popliteal artery

          -  intolerance to antiplatelet drugs (antiaggregants)

          -  known allergies to GORE VIABAHN® stent graft materials/composition

          -  emergency surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Nellie DELLA SCHIAVA, MD</last_name>
    <phone>4 72 11 76 76</phone>
    <phone_ext>+33</phone_ext>
    <email>dellaschiava.nellie@neuf.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hôpital pneumologique et cardiovasculaire Louis Pradel (HCL)</name>
      <address>
        <city>Bron</city>
        <zip>69677</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Nellie DELLA SCHIAVA, MD</last_name>
      <phone>4 72 11 76 76</phone>
      <phone_ext>+33</phone_ext>
      <email>dellaschiava.nellie@neuf.fr</email>
    </contact>
    <investigator>
      <last_name>Nellie DELLA SCHIAVA, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>June 21, 2019</study_first_submitted>
  <study_first_submitted_qc>June 21, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 25, 2019</study_first_posted>
  <last_update_submitted>July 3, 2019</last_update_submitted>
  <last_update_submitted_qc>July 3, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 8, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

